日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

JAK inhibitor selection in challenging scenarios of myelofibrosis: a review

在骨髓纤维化复杂情况下选择JAK抑制剂:综述

Vachhani, Pankit; Mesa, Ruben; Mascarenhas, John; Rampal, Raajit; Oh, Stephen T; Vannucchi, Alessandro Maria; Fox, Maria Laura; Palandri, Francesca; Passamonti, Francesco; Kiladjian, Jean-Jacques; Azimi, Mahshid; Harrison, Claire; Bose, Prithviraj

Anaphylaxis events in the PIONEER study of avapritinib in indolent systemic mastocytosis

在 PIONEER 研究中,avapritinib 治疗惰性系统性肥大细胞增生症期间发生的过敏反应事件

Pongdee, Thanai; Castells, Mariana; Akin, Cem; Dybedal, Ingunn; Gotlib, Jason; Panse, Jens Peter; Alvarez-Twose, Ivan; Cabeza, Cristina Morales; Cerquozzi, Sonia; Vadas, Peter; Swarup, Vidushi; Vachhani, Pankit; Wortmann, Friederike; Yi, Cecilia Arana; Bidollari, Ilda; Newberry, Kate; Shaheen, Daniel; Hartmann, Karin

Case Report: KMT2A amplification in two adult patients with B-cell acute lymphoblastic leukemia

病例报告:两例成人B细胞急性淋巴细胞白血病患者的KMT2A扩增

Gao, Min; Chen, Yunjia; Bachiashvili, Kimo; Vachhani, Pankit J; Jamy, Omer; Harada, Shuko; Mackinnon, Alexander Craig; Singh, Nirupama; Ravindran, Aishwarya; Reddy, Baleed Vishnu; Carroll, Andrew J; Mikhail, Fady M

POIESIS: a phase III study of add-on navtemadlin in JAK inhibitor-naïve myelofibrosis patients with a suboptimal response to ruxolitinib

POIESIS:一项针对对鲁索替尼反应欠佳的JAK抑制剂初治骨髓纤维化患者的附加navtemadlin III期研究

Vachhani, Pankit; Yacoub, Abdulraheem; Rampal, Raajit; Bradley, Terrence; Harrison, Claire; Jain, Tania; Kuykendall, Andrew; Palandri, Francesca; Mascarenhas, John; Al-Ali, Haifa; Passamonti, Francesco; Rothbaum, Wayne; Verstovsek, Srdan; Heidel, Florian H

Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial

接受帕纳替尼或伊马替尼治疗的费城染色体阳性急性淋巴细胞白血病患者的患者报告结局:来自 PhALLCON 试验的结果

Ashaye, Ajibade; Shi, Ling; Aldoss, Ibrahim; Montesinos, Pau; Vachhani, Pankit; Rocha, Vanderson; Papayannidis, Cristina; Leonard, Jessica T; Baer, Maria R; Ribera, Jose-Maria; McCloskey, James; Wang, Jianxiang; Gao, Sujun; Rane, Deepali; Guo, Shien

A phase I/IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosis

一项针对晚期骨髓纤维化的新型泛赖氨酰氧化酶抑制剂 PXS-5505 的 I/IIa 期试验

Vachhani, Pankit; Tan, Peter; Watson, Anne-Marie; Wu, Shang-Ju; Baker, Ross; Cheung, Stanley; Lee, Sung-Eun; Chen, Chih-Cheng; Chen, Tsai-Yun; Hsiao, Hui-Hua; Lee, Jae Hoon; Masarova, Lucia; Tan, Shuh Ying; Baskar, Jana; Charlton, Brett; Findlay, Alison; Hamprecht, Dieter; Jarolimek, Wolfgang; Leadbetter, Joanna; Miller, John; Morgan, Kristen; Zahoor, Amna; Hobbs, Gabriela

Real-world treatment patterns and health care resource use for patients with myelofibrosis: results from the METER study

骨髓纤维化患者的真实世界治疗模式和医疗资源利用情况:METER 研究的结果

Gupta, Vikas; Tomuleasa, Ciprian; Barranco Lampón, Gilberto Israel; Hou, Hsin-An; Helbig, Grzegorz; Vachhani, Pankit; Symeonidis, Argiris; Haznedaroglu, Ibrahim; Galvez, Kenny; Tatsch, Fernando; Chopra, Avijeet S; Zhang, Meng; Vizkelety, Tamas; Murray, Bryan; Ross, David M

Real-World Evidence of Treatment-Free Remission Strategies and Outcomes in Chronic Myeloid Leukemia

慢性粒细胞白血病无治疗缓解策略及结果的真实世界证据

Bourne, Garrett; Diebold, Kendall; Bascug, Greg; Knapp, Joshua; Espinoza-Gutarra, Manuel; Vachhani, Pankit; Bachiashvili, Kimo; Rangaraju, Sravanti; Mohty, Razan; Bhatia, Ravi; Jamy, Omer

Quality-Adjusted Time Without Symptoms of Disease or Toxicity (Q-TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Comparison of Ponatinib Versus Imatinib

新诊断费城染色体阳性急性淋巴细胞白血病患者的无疾病或毒性症状质量调整时间 (Q-TWiST):帕纳替尼与伊马替尼的比较

Ashaye, Ajibade; Shi, Ling; Aldoss, Ibrahim; Montesinos, Pau; Vachhani, Pankit; Rocha, Vanderson; Papayannidis, Cristina; Leonard, Jessica T; Baer, Maria R; Ribera, Jose-Maria; McCloskey, James; Wang, Jianxiang; Rane, Deepali; Guo, Shien

A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial

一项在美国和加拿大开展的多中心研究旨在评估罗培干扰素α-2b-njft治疗原发性血小板增多症患者的疗效、安全性和耐受性:EXCEED-ET试验

Masarova, Lucia; Reeves, Brandi N; El Chaer, Firas; Foltz, Lynda; Tashi, Tsewang; Abu-Zeinah, Ghaith; Lucas, Jennifer; Halpern, Anna B; Maze, Dawn; Qin, Albert; Safah, Hana; Lan, Fengshuo; O'Connell, Casey L; Goel, Swati; Rein, Lindsay; Fang, Bruno; How, Joan; Babu, Sunil; Li, Zhuoyan; Cerquozzi, Sonia; Oh, Stephen T; Hunter, Anthony M; Podoltsev, Nikolai; Vachhani, Pankit; Yacoub, Abdulraheem; Cunningham, Julia M; Hillis, Christopher; Otoukesh, Salman; Zagrijtschuk, Oleh; Castro, Henry; Bose, Prithviraj